Global Vaccine Adjuvants Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Vaccine Adjuvants Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type
  • 1.4.2 Oral
  • 1.4.3 Subcutaneous
  • 1.2.4 Intramuscular
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application
  • 1.3.2 Veterinary Vaccine Adjuvants (Research Applications, Commercial Applications)
  • 1.3.3 Human Vaccine Adjuvants (Research Applications, Commercial Applications)
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Vaccine Adjuvants Sales Estimates and Forecasts 2016-2027
• 2.2 Global Vaccine Adjuvants Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Vaccine Adjuvants Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Vaccine Adjuvants Regions by Sales
  • 2.4.1 Global Top Vaccine Adjuvants Regions by Sales (2016-2021)
  • 2.4.2 Global Top Vaccine Adjuvants Regions by Sales (2022-2027)
• 2.5 Global Top Vaccine Adjuvants Regions by Revenue
  • 2.5.1 Global Top Vaccine Adjuvants Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Vaccine Adjuvants Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Vaccine Adjuvants Sales by Manufacturers
  • 3.1.1 Global Top Vaccine Adjuvants Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Vaccine Adjuvants Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Vaccine Adjuvants Sales in 2020
• 3.2 Global Vaccine Adjuvants Revenue by Manufacturers
  • 3.2.1 Global Top Vaccine Adjuvants Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Vaccine Adjuvants Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Vaccine Adjuvants Revenue in 2020
• 3.3 Global Vaccine Adjuvants Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Vaccine Adjuvants Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Vaccine Adjuvants Sales by Type
  • 4.1.1 Global Vaccine Adjuvants Historical Sales by Type (2016-2021)
  • 4.1.2 Global Vaccine Adjuvants Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2016-2027)
• 4.2 Global Vaccine Adjuvants Revenue by Type
  • 4.2.1 Global Vaccine Adjuvants Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Vaccine Adjuvants Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2016-2027)
• 4.3 Global Vaccine Adjuvants Price by Type
  • 4.3.1 Global Vaccine Adjuvants Price by Type (2016-2021)
  • 4.3.2 Global Vaccine Adjuvants Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Vaccine Adjuvants Sales by Application
  • 5.1.1 Global Vaccine Adjuvants Historical Sales by Application (2016-2021)
  • 5.1.2 Global Vaccine Adjuvants Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2016-2027)
• 5.2 Global Vaccine Adjuvants Revenue by Application
  • 5.2.1 Global Vaccine Adjuvants Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Vaccine Adjuvants Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2016-2027)
• 5.3 Global Vaccine Adjuvants Price by Application
  • 5.3.1 Global Vaccine Adjuvants Price by Application (2016-2021)
  • 5.3.2 Global Vaccine Adjuvants Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Vaccine Adjuvants Market Size by Type
  • 6.1.1 North America Vaccine Adjuvants Sales by Type (2016-2027)
  • 6.1.2 North America Vaccine Adjuvants Revenue by Type (2016-2027)
• 6.2 North America Vaccine Adjuvants Market Size by Application
  • 6.2.1 North America Vaccine Adjuvants Sales by Application (2016-2027)
  • 6.2.2 North America Vaccine Adjuvants Revenue by Application (2016-2027)
• 6.3 North America Vaccine Adjuvants Market Size by Country
  • 6.3.1 North America Vaccine Adjuvants Sales by Country (2016-2027)
  • 6.3.2 North America Vaccine Adjuvants Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Vaccine Adjuvants Market Size by Type
  • 7.1.1 Europe Vaccine Adjuvants Sales by Type (2017-2027)
  • 7.1.2 Europe Vaccine Adjuvants Revenue by Type (2017-2027)
• 7.2 Europe Vaccine Adjuvants Market Size by Application
  • 7.2.1 Europe Vaccine Adjuvants Sales by Application (2017-2027)
  • 7.2.2 Europe Vaccine Adjuvants Revenue by Application (2017-2027)
• 7.3 Europe Vaccine Adjuvants Market Size by Country
  • 7.3.1 Europe Vaccine Adjuvants Sales by Country (2017-2027)
  • 7.3.2 Europe Vaccine Adjuvants Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Vaccine Adjuvants Market Size by Type
  • 8.1.1 Asia Pacific Vaccine Adjuvants Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Vaccine Adjuvants Revenue by Type (2018-2027)
• 8.2 Asia Pacific Vaccine Adjuvants Market Size by Application
  • 8.2.1 Asia Pacific Vaccine Adjuvants Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Vaccine Adjuvants Revenue by Application (2018-2027)
• 8.3 Asia Pacific Vaccine Adjuvants Market Size by Region
  • 8.3.1 Asia Pacific Vaccine Adjuvants Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Vaccine Adjuvants Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Vaccine Adjuvants Market Size by Type
  • 9.1.1 Latin America Vaccine Adjuvants Sales by Type (2019-2027)
  • 9.1.2 Latin America Vaccine Adjuvants Revenue by Type (2019-2027)
• 9.2 Latin America Vaccine Adjuvants Market Size by Application
  • 9.2.1 Latin America Vaccine Adjuvants Sales by Application (2019-2027)
  • 9.2.2 Latin America Vaccine Adjuvants Revenue by Application (2019-2027)
• 9.3 Latin America Vaccine Adjuvants Market Size by Country
  • 9.3.1 Latin America Vaccine Adjuvants Sales by Country (2019-2027)
  • 9.3.2 Latin America Vaccine Adjuvants Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Vaccine Adjuvants Market Size by Type
  • 6.1.1 Middle East and Africa Vaccine Adjuvants Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Vaccine Adjuvants Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Vaccine Adjuvants Market Size by Application
  • 6.2.1 Middle East and Africa Vaccine Adjuvants Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Vaccine Adjuvants Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Vaccine Adjuvants Market Size by Country
  • 6.3.1 Middle East and Africa Vaccine Adjuvants Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Vaccine Adjuvants Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 SEPPIC
  • 11.1.1 SEPPIC Corporation Information
  • 11.1.2 SEPPIC Overview
  • 11.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 SEPPIC Vaccine Adjuvants Product Description
  • 11.1.5 SEPPIC Related Developments
• 11.2 SDA BIO
  • 11.2.1 SDA BIO Corporation Information
  • 11.2.2 SDA BIO Overview
  • 11.2.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 SDA BIO Vaccine Adjuvants Product Description
  • 11.2.5 SDA BIO Related Developments
• 11.3 Croda International Plc
  • 11.3.1 Croda International Plc Corporation Information
  • 11.3.2 Croda International Plc Overview
  • 11.3.3 Croda International Plc Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Croda International Plc Vaccine Adjuvants Product Description
  • 11.3.5 Croda International Plc Related Developments
• 11.4 SPI Pharma
  • 11.4.1 SPI Pharma Corporation Information
  • 11.4.2 SPI Pharma Overview
  • 11.4.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 SPI Pharma Vaccine Adjuvants Product Description
  • 11.4.5 SPI Pharma Related Developments
• 11.5 Phibro Animal Health Corporation
  • 11.5.1 Phibro Animal Health Corporation Corporation Information
  • 11.5.2 Phibro Animal Health Corporation Overview
  • 11.5.3 Phibro Animal Health Corporation Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 Phibro Animal Health Corporation Vaccine Adjuvants Product Description
  • 11.5.5 Phibro Animal Health Corporation Related Developments
• 11.6 Tj Kaiwei
  • 11.6.1 Tj Kaiwei Corporation Information
  • 11.6.2 Tj Kaiwei Overview
  • 11.6.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Tj Kaiwei Vaccine Adjuvants Product Description
  • 11.6.5 Tj Kaiwei Related Developments
• 11.7 Novavax
  • 11.7.1 Novavax Corporation Information
  • 11.7.2 Novavax Overview
  • 11.7.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Novavax Vaccine Adjuvants Product Description
  • 11.7.5 Novavax Related Developments
• 11.8 Zhuoyue
  • 11.8.1 Zhuoyue Corporation Information
  • 11.8.2 Zhuoyue Overview
  • 11.8.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Zhuoyue Vaccine Adjuvants Product Description
  • 11.8.5 Zhuoyue Related Developments
• 11.9 Aphios
  • 11.9.1 Aphios Corporation Information
  • 11.9.2 Aphios Overview
  • 11.9.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Aphios Vaccine Adjuvants Product Description
  • 11.9.5 Aphios Related Developments
• 11.10 GSK
  • 11.10.1 GSK Corporation Information
  • 11.10.2 GSK Overview
  • 11.10.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 GSK Vaccine Adjuvants Product Description
  • 11.10.5 GSK Related Developments
• 11.1 SEPPIC
  • 11.1.1 SEPPIC Corporation Information
  • 11.1.2 SEPPIC Overview
  • 11.1.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 SEPPIC Vaccine Adjuvants Product Description
  • 11.1.5 SEPPIC Related Developments
• 11.12 Brenntag Biosector
  • 11.12.1 Brenntag Biosector Corporation Information
  • 11.12.2 Brenntag Biosector Overview
  • 11.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 Brenntag Biosector Product Description
  • 11.12.5 Brenntag Biosector Related Developments
• 11.13 SEPPIC
  • 11.13.1 SEPPIC Corporation Information
  • 11.13.2 SEPPIC Overview
  • 11.13.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 SEPPIC Product Description
  • 11.13.5 SEPPIC Related Developments
• 11.14 SPI Pharma
  • 11.14.1 SPI Pharma Corporation Information
  • 11.14.2 SPI Pharma Overview
  • 11.14.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 SPI Pharma Product Description
  • 11.14.5 SPI Pharma Related Developments
• 11.15 Novavax
  • 11.15.1 Novavax Corporation Information
  • 11.15.2 Novavax Overview
  • 11.15.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Novavax Product Description
  • 11.15.5 Novavax Related Developments
• 11.16 Avanti Polar Lipids
  • 11.16.1 Avanti Polar Lipids Corporation Information
  • 11.16.2 Avanti Polar Lipids Overview
  • 11.16.3 Avanti Polar Lipids Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.16.4 Avanti Polar Lipids Product Description
  • 11.16.5 Avanti Polar Lipids Related Developments
• 11.17 Aphios
  • 11.17.1 Aphios Corporation Information
  • 11.17.2 Aphios Overview
  • 11.17.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.17.4 Aphios Product Description
  • 11.17.5 Aphios Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Vaccine Adjuvants Value Chain Analysis
• 12.2 Vaccine Adjuvants Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Vaccine Adjuvants Production Mode & Process
• 12.4 Vaccine Adjuvants Sales and Marketing
  • 12.4.1 Vaccine Adjuvants Sales Channels
  • 12.4.2 Vaccine Adjuvants Distributors
• 12.5 Vaccine Adjuvants Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Vaccine Adjuvants Industry Trends
• 13.2 Vaccine Adjuvants Market Drivers
• 13.3 Vaccine Adjuvants Market Challenges
• 13.4 Vaccine Adjuvants Market Restraints

14 Key Findings in The Global Vaccine Adjuvants Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details